Literature DB >> 30515695

Synergistic effects of TIMP2-418G/C and MMP9-1562C/T variants on the male infertility risk.

Shiva Roshankhah1, Kamran Mansouri2, Mitra Bakhtiari1, Mohammad Reza Salahshoor1, Rezvan Asgari3.   

Abstract

Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) involve in the degradation of the extracellular matrix (ECM) that imbalances their activity and may lead to various diseases. The present study aims to evaluate the association between MMP9-1562C/T and TIMP2-418G/C variants and synergistic effects of both variants on male infertility in an Iranian population. We analyzed these polymorphisms in 101 infertile men and 106 fertile men as a control group using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Based on the obtained results, no considerable association was observed in MMP9-1562C/T polymorphism frequency between infertile men and controls while frequencies of TIMP2-418G/C variant were significantly different in infertile and control groups (P = 0.028). Men with CC, GC and CC + GC genotypes for TIMP2-418G/C polymorphism had an increased risk of infertility compared to men with GG genotype [OR = 1.85, 95% CI (0.917-3.734, P = 0.086), OR = 1.94, 95% CI (1.098-3.437, P = 0.023) and OR = 2.053 95% CI (1.179-3.577, P = 0.011), respectively]. Also, in the presence of both TIMP2-418C and MMP9-1562T alleles the male infertility risk was significantly increased (P = 0.032). The current study suggests that the variation of TIMP2 gene and its interaction with MMP9 gene might be associated with male infertility. However, to confirm these findings, further studies are required in different ethnicities and with a larger sample size.

Entities:  

Keywords:  Interaction; Male infertility; Matrix metalloproteinases; Polymorphism; Tissue inhibitors of metalloproteinases

Mesh:

Substances:

Year:  2018        PMID: 30515695     DOI: 10.1007/s11033-018-4541-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

Review 1.  TIMPs as multifacial proteins.

Authors:  Elise Lambert; Emilie Dassé; Bernard Haye; Emmanuelle Petitfrère
Journal:  Crit Rev Oncol Hematol       Date:  2004-03       Impact factor: 6.312

2.  Quantitative differences in matrix metalloproteinase (MMP)-2, but not in MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 or TIMP-2, in seminal plasma of normozoospermic and azoospermic patients.

Authors:  E Baumgart; S V Lenk; S A Loening; K Jung
Journal:  Hum Reprod       Date:  2002-11       Impact factor: 6.918

3.  Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.

Authors:  Bo Peng; Lihuan Cao; Xiaopin Ma; Wenzhang Wang; Dan Wang; Long Yu
Journal:  Mutagenesis       Date:  2010-04-01       Impact factor: 3.000

4.  Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.

Authors:  Kyung Sook Park; Seon Jeong Kim; Kyung Ho Kim; Jin Cheon Kim
Journal:  J Gastroenterol Hepatol       Date:  2011-02       Impact factor: 4.029

5.  Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

Authors:  B Zhang; S Ye; S M Herrmann; P Eriksson; M de Maat; A Evans; D Arveiler; G Luc; F Cambien; A Hamsten; H Watkins; A M Henney
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

Review 6.  The clinical management of male infertility.

Authors:  K Razvi; S Chew; E L Yong; J Kumar; S C Ng
Journal:  Singapore Med J       Date:  1999-04       Impact factor: 1.858

7.  Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.

Authors:  Yifeng Zhou; Chunyuan Yu; Xiaoping Miao; Wen Tan; Gang Liang; Ping Xiong; Tong Sun; Dongxin Lin
Journal:  Carcinogenesis       Date:  2003-11-06       Impact factor: 4.944

8.  Matrix metalloproteinase (MMP)-2 and MMP-9 in seminal plasma.

Authors:  Ioannis Tentes; Byron Asimakopoulos; Efthimia Mourvati; Klaus Diedrich; Safaa Al-Hasani; Nikos Nikolettos
Journal:  J Assist Reprod Genet       Date:  2007-07-07       Impact factor: 3.412

9.  Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

Authors:  F J G M Kubben; C F M Sier; M J W Meijer; M van den Berg; J J van der Reijden; G Griffioen; C J H van de Velde; C B H W Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  2006-08-29       Impact factor: 7.640

10.  Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.

Authors:  Janusz K Rybakowski
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-31
View more
  2 in total

Review 1.  Genetics and molecular biology of male infertility among Iranian population: an update.

Authors:  Majid Mojarrad; Ehsan Saburi; Alireza Golshan; Meysam Moghbeli
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Association between the FAS/FASL Variants and Risk of Male Infertility in Asian Populations; A Systematic Review and Meta-Analysis.

Authors:  Rezvan Asgari; Kamran Mansouri; Mitra Bakhtiari; Hadi Mozafari; Shiva Roshankhah
Journal:  Medicina (Kaunas)       Date:  2019-06-05       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.